Show simple item record

dc.contributor.authorBaricevic, Ivona
dc.contributor.authorHe, Xiaotong
dc.contributor.authorChakrabarty, Bipasha
dc.contributor.authorOliver, A
dc.contributor.authorBailey, C
dc.contributor.authorSummers, J
dc.contributor.authorHampson, L
dc.contributor.authorHampson, I
dc.contributor.authorGilbert, D
dc.contributor.authorRenehan, Andrew G
dc.date.accessioned2015-03-19T11:33:04Zen
dc.date.available2015-03-19T11:33:04Zen
dc.date.issued2015-02-19en
dc.identifier.citationHigh-sensitivity human papilloma virus genotyping reveals near universal positivity in anal squamous cell carcinoma: Different implications for vaccine prevention and prognosis. 2015: Eur J Canceren
dc.identifier.issn1879-0852en
dc.identifier.pmid25702585en
dc.identifier.doi10.1016/j.ejca.2015.01.058en
dc.identifier.urihttp://hdl.handle.net/10541/346890en
dc.description.abstractCharacterisation of human papilloma virus (HPV) infection in anal squamous cell carcinoma (ASCC) may have dual importance: first, aetiological; second, prognostic, informing outcome after chemo-radiotherapy (CRT). We undertook HPV genotyping, and allelic characterisations, to evaluate the aetiological role of HPV while simultaneously evaluating the impact of HPV genotyping on relapse-free (RFS) and overall survival (OS).
dc.languageENGen
dc.language.isoenen
dc.rightsArchived with thanks to European journal of cancer (Oxford, England : 1990)en
dc.titleHigh-sensitivity human papilloma virus genotyping reveals near universal positivity in anal squamous cell carcinoma: Different implications for vaccine prevention and prognosis.en
dc.typeArticleen
dc.contributor.departmentViral Oncology Group, Institute of Cancer Sciences, University of Manchester, Manchester.en
dc.identifier.journalEuropean Journal of Canceren
html.description.abstractCharacterisation of human papilloma virus (HPV) infection in anal squamous cell carcinoma (ASCC) may have dual importance: first, aetiological; second, prognostic, informing outcome after chemo-radiotherapy (CRT). We undertook HPV genotyping, and allelic characterisations, to evaluate the aetiological role of HPV while simultaneously evaluating the impact of HPV genotyping on relapse-free (RFS) and overall survival (OS).


Files in this item

This item appears in the following Collection(s)

Show simple item record